Risk of malignancy in Korean patients with primary Sjogren's syndrome
- Authors
- Kang, Juyeon; Kim, Hyoungyoung; Kim, Jinwook; Choi, Seongmi; Jung, Sun-Young; Jang, Eun Jin; Cho, Soo-Kyung; Sung, Yoon-Kyoung
- Issue Date
- Aug-2020
- Publisher
- WILEY
- Keywords
- hematologic malignancy; incidence; primary Sjogren's syndrome; solid malignancy
- Citation
- INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, v.23, no.9, pp 1240 - 1247
- Pages
- 8
- Journal Title
- INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
- Volume
- 23
- Number
- 9
- Start Page
- 1240
- End Page
- 1247
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/53525
- DOI
- 10.1111/1756-185X.13927
- ISSN
- 1756-1841
1756-185X
- Abstract
- Objectives To evaluate the risks of overall and site-specific malignancies in Korean patients with primary Sjogren's syndrome (pSS). Methods Using the Korean nationwide healthcare claims database, we constructed a retrospective cohort for prevalent pSS aged over 50 years. After enrollment between January 2012 and December 2014, patients were followed until the development of any malignancy, or until December 2015. Crude incidence rates of malignancies of pSS patients were calculated, and their standardized incidence ratios (SIRs) for malignancies were calculated compared to those in knee osteoarthritis (OA) patients. Results A total of 6,359 pSS and 5,476,302 knee OA patients were included in this study. During follow-up (19,474 person-years [PYs]), 310 cases of solid malignancy (158.8/10,000 PYs) and 47 cases of hematologic malignancies (23.5/10,000 PYs) were observed in pSS patients. The risks of overall (SIR 1.30, 95% CI 1.16-1.43), solid (SIR 1.16, 95% CI 1.03-1.29), and hematologic malignancies (SIR 4.80, 95% CI 3.43-6.17) were increased in pSS patients. There was an elevated risk of site-specific malignancy in non-Hodgkin's lymphoma (NHL, SIR 6.45, 95% CI 4.05-8.83), multiple myeloma (SIR 4.88, 95% CI 2.00-7.76), and oropharynx (SIR 4.16, 95% CI 1.90-6.42). The risk of lung cancer was increased only in male pSS patients (2.50, 95% CI 1.02-3.99), while the risk of thyroid cancer was increased in female patients (1.44, 95% CI 1.04, 1.84). Conclusion In patients with pSS over age 50, the risk of solid cancers such as oropharynx, thyroid, and lung cancers is also increased in addition to NHL.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Pharmacy > School of Pharmacy > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/53525)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.